Vidalta is licensed for the treatment of hyperthyroidism, a common hormonal disease of middle aged to older cats. Vidalta only needs to be given once daily as the tablets are formulated to release the active, carbimazole, over twenty four hours.
10 mg prolonged-release tablets
15 mg prolonged-release tablets
Vidalta 10 mg tablets contain 10 mg carbimazole as active ingredient
Vidalta 15 mg tablets contain 15 mg carbimazole as active ingredient.
Indications for use
Treatment of hyperthyroidism and hyperthyroidism-associated clinical signs in cats.
30 or 100 Vidalta 10 mg or 15 mg tablets in a white high-density polyethylene tub.
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Date of preparation: January 2018